Glospor SB 130mg Capsule contains Itraconazole 130mg, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. This medication is indicated for the management of systemic and superficial mycoses, including aspergillosis, histoplasmosis, blastomycosis, onychomycosis, and other dermatophytic infections. Glospor SB is particularly effective against infections caused by Candida species and dermatophytes. The capsule formulation ensures optimal bioavailability and patient compliance. It is recommended to be taken with food to enhance absorption. Dosage and duration of therapy depend on the type and severity of the infection, and treatment should be guided by clinical response and, where appropriate, laboratory monitoring. Caution is advised in patients with hepatic impairment or congestive heart failure, and it should be used with care in individuals taking medications metabolized by the cytochrome P450 system due to potential drug interactions. Adverse effects may include gastrointestinal disturbances, headache, and rash. Consultation with a healthcare professional is essential before initiating therapy with Glospor SB 130mg Capsule.